Chiesi Italia is the Italian subsidiary of the Chiesi Group, a major Italian pharmaceutical company headquartered in Parma. The company focuses its work on three main areas: Air, Rare and Care, developing and providing pharmaceutical products for respiratory conditions and rare diseases. Its portfolio includes respiratory inhalers and treatments for rare disorders, with research and development supporting the advancement of therapies and delivery technologies.

Chiesi Italia is also involved in initiatives that address patients’ experiences and needs, including projects that raise awareness of respiratory and rare diseases. Alongside its healthcare activities, the company works to reduce the environmental impact of its products. This includes developing inhalers with lower-impact propellants and supporting the recovery and proper disposal of used inhalers through the Recupera e Respira project.

The company reports on its social and environmental impact and highlights sustainability, ethical conduct, transparency and workplace wellbeing as part of its wider commitments. Through its products, research, patient-focused initiatives and environmental programs, Chiesi Italia connects pharmaceutical innovation with care for people and the communities it serves.